Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · IEX Real-Time Price · USD
0.701
-0.027 (-3.68%)
At close: Jul 19, 2024, 4:00 PM
0.650
-0.051 (-7.30%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $3.12 million as of July 22, 2024. Its market cap has decreased by -64.52% in one year.
Market Cap
3.12M
Enterprise Value
698.13K
1-Year Change
-64.52%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since December 2, 2010, Protagenic Therapeutics's market cap has decreased from $10.30M to $3.12M, a decrease of -69.69%. That is a compound annual growth rate of -8.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.10M | -29.55% |
| Dec 29, 2023 | 4.40M | -36.23% |
| Dec 30, 2022 | 6.90M | -70.64% |
| Dec 31, 2021 | 23.50M | 115.60% |
| Dec 31, 2020 | 10.90M | -24.83% |
| Dec 31, 2019 | 14.50M | -29.27% |
| Dec 31, 2018 | 20.50M | -9.29% |
| Dec 29, 2017 | 22.60M | -45.54% |
| Dec 30, 2016 | 41.50M | 41,400.00% |
| Dec 31, 2015 | 100.00K | -80.00% |
| Dec 31, 2014 | 500.00K | - |
| Dec 31, 2013 | - | - |
| Dec 31, 2012 | - | -100.00% |
| Dec 30, 2011 | 100.00K | -99.39% |
| Dec 31, 2010 | 16.40M | 59.22% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ensysce Biosciences | 3.30M |
| ZyVersa Therapeutics | 3.26M |
| Avenue Therapeutics | 3.25M |
| Healthcare Triangle | 3.20M |
| Aditxt | 3.19M |
| CNS Pharmaceuticals | 3.01M |
| Petros Pharmaceuticals | 3.01M |
| Alzamend Neuro | 2.97M |